Site icon pharmaceutical daily

Cell Therapy Market and Technology Forecast, 2028 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Cell Therapy – Market and Technology Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering.

The global revenue of the cell therapy market is estimated to be around USD 6 billion in the year 2020 and the market is projected to grow to a value of 9 Billion by the year 2028. The growth momentum for this market segment is accounted to be 6%.

The key driver of this market is the increased funding from the government as well as private organizations to support clinical studies in the field of cell therapy. Moreover, the growing application of regenerative medicine further propels the market growth. The development of precision medicine and advancements in the field of ATMPS (Advanced Therapies Medicinal Products) (ATMPS) are expected to be the major drivers for the market. The use of cell therapy in clinical studies is the key application of this sector that propels the market growth.

North America governs the largest segment of the global market, this is due to major research institutes of this field being located in the US like the Institute for Stem Cell Biology, Stanford, and Yale Stem Cell Centre in the US. Canada as well as the U.S, has been providing funds for scientific research in the field of cell therapy which has been driving the market. APAC is the fastest-growing market segment of this market globally, owing to the growing infrastructure for research that supports and promotes this field.

Scope:

The report is aimed at:

Segmentation covered in this report

By End User

By Region

By cell type

By process

By product

Country Level Analysis

For more information about this report visit https://www.researchandmarkets.com/r/m5ehzk

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Exit mobile version